Treatment Archives | Mesothelioma.com | Page 1 of 15

Categories

Image depicts a hanging bag of intravenous immunotherapy drugs behind the title text: Immunotherapy for Peritoneal Mesothelioma.

4 Things to Know About Immunotherapy for Peritoneal Mesothelioma

December 1st, 2022 by Katy Moncivais, Ph.D.

A multidisciplinary tumor board sits at a rectangular table reviewing a mesothelioma case. The board includes a thoracic surgeon, a radiologist, a pathologist and a medical oncologist.

Study: 3 Important Benefits of Specialty Mesothelioma Care

November 17th, 2022 by Katy Moncivais, Ph.D.

A service animal gets a hug from a mesothelioma patient.

Benefits of Support Animals for Cancer Patients

October 20th, 2022 by Tara Strand

A bag of mesothelioma immunotherapy drugs hangs from an IV stand in front of a window.

Immunotherapy Made a Mesothelioma Patient Eligible for Surgery

October 13th, 2022 by Katy Moncivais, Ph.D.

A mesothelioma patient with cropped, salt and pepper hair walks along a seaside cliff.

Three Encouraging Traits of Cancer Patients Who Outlived Their Life Expectancies

September 29th, 2022 by Katy Moncivais, Ph.D.

The gloved hand of a researcher places a slide onto the viewing stage of a microscope. The slide contains tissue from a peritoneal mesothelioma tumor.

Study Implies Future Immunotherapy Success in Peritoneal Mesothelioma

September 1st, 2022 by Katy Moncivais, Ph.D.

A masked doctor wearing green gloves uses a small syringe to withdraw an experimental cancer vaccine from a glass vial. The vaccine will be part of a mesothelioma treatment regimen.

Mesothelioma Cancer Vaccine Steps Closer to Reality

August 18th, 2022 by Katy Moncivais, Ph.D.

A pleural mesothelioma trial doctor holds a clipboard showing 100% survival of study patients one year after treatment. The clipboard and the doctor's gloved hands are in the foreground on the left, and an out-of-focus chest x-ray is in the background on the right.

Small Study Reports 100% One-Year Survival Rate for Pleural Mesothelioma

August 4th, 2022 by Katy Moncivais, Ph.D.